The research has shown that selected exposure modes of LILR in women with CSO are adjusted and dosed, suggesting obvious pathogenetic effects of infrared radiation.
The efficiency of LILR therapy in women with CSO is also confirmed by the results of changing dynamics of cytokine inflammatory mediator levels in blood, namely, a more marked decrease in levels of proinflammatory IL-1[beta], 6 in Group II than in Group I.
Finally, the use of LILR in the treatment of CSO in women leads to a more favorable outcome of the disease such as the reduced number of disease recurrences and complications compared to traditional medication treatment.
Unit Unit price sales sales LEADING BRANDS ** per unit (000) % change Pepto-Bismol $5.08 498 -2.9% Align 29.56 159 -16.0% Pepto-Bismol InstaCool 6.25 43 -- Phillips 6.20 17 -23.8% Equalactin 8.20 7 -17.3% Dual-Action Cleanse 40.00 6 -23.8% Digestive Advantage 9.07 1 -- Lilr
Drug Store Pepto-Bismol 1.29 -- -- Unis Pepto-Bismol 1.08 -- +58.4% Handy Solutions Pepto-Bismol 1.88 -- -89.9% * Total of drug stores, supemtarkets and discount stores excluding WalmarL ** In drug stores only.